GEXVal CTO to Present at the Annual Meeting of the PSJNew!!
2026年3月25日
株式会社GEXValMarch 25, 2026 GEXVal CTO to Present at the 146th Annual Meeting of the Pharmaceutical Society of Ja […]
CTO Nakayama Contributes Invited Article to Experimental Medicine, Japan’s Leading Life Science Journal, on AI-Driven Drug Discovery
2026年3月12日
株式会社GEXValMarch 12, 2026 CTO Nakayama Contributes Invited Article to Experimental Medicine Special Issue on AI […]
Rare Disease Day Update: FRAXA Features GEXVal’s FRAXA-DVI Completion and FDA Orphan Drug Designation
2026年2月28日
GEXVal Inc.February 28, 2026 FRAXA Research Foundation Features GEXVal's Completion of FRAXA-DVI Program and F […]
GEXVal Selected as Presenting Company at Biotech Showcase™ 2026
2026年1月7日
株式会社GEXValJanuary 7, 2026 GEXVal Selected as Presenting Company at Biotech Showcase™ 2026 GEXVal Inc. (Preside […]
GEXVal Featured in BioCentury Article
2025年12月22日
株式会社GEXValDecember 22, 2025 GEXVal Featured in BioCentury Article “Raising the Sun: Japan Biotech Looks to Lev […]